Schizophrenia Biomarkers: Blood Transcriptome Suggests Two Molecular Subtypes

Area of Science:

• Neuroscience
• Genetics
• Computational Biology

Background:

• Schizophrenia is a complex, chronic mental disorder with significant genetic influences.
• Its clinical and genetic heterogeneity complicates identifying causal factors.
• Existing research highlights the burden on patients, families, and healthcare systems.

Purpose of the Study:

• To analyze blood transcriptomes for molecular subtypes of schizophrenia.
• To identify key genes and pathways associated with schizophrenia subtypes.
• To develop a predictive model for schizophrenia based on gene expression.

Main Methods:

• Analysis of blood transcriptomes from 398 individuals (212 patients, 186 controls) across five public datasets.
• Unsupervised machine learning for clustering patients into molecular subtypes.
• Gene enrichment analysis focusing on ribosome and ubiquitin-proteasome pathways.
• Development of a logistic regression model for schizophrenia prediction.

Main Results:

• Two distinct molecular subtypes of schizophrenia were identified through clustering.
• Key genes involved in ribosome and ubiquitin-proteasome pathways were significantly associated with subtypes.
• A predictive model achieved 64% positive predictive value for schizophrenia in independent datasets (p=0.039).

Conclusions:

• Blood transcriptomics can reveal molecular subtypes in schizophrenia, reflecting its heterogeneity.
• Ribosome and ubiquitin-proteasome pathways are implicated in schizophrenia pathophysiology.
• This approach may facilitate personalized medicine and novel therapeutic strategies for schizophrenia.